If you can't beat 'em, join 'em. Pro sports leagues have learned to embrace rather than resist the secondary ticket market, writes ESPN.com's John Helyar.
If it isn't steroids, it's HGH. If it isn't HGH, it's genetic doping. John Helyar looks at the lopsided odds in the fight against performance-enhancers in sports.